IL68456A - Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles - Google Patents

Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles

Info

Publication number
IL68456A
IL68456A IL68456A IL6845683A IL68456A IL 68456 A IL68456 A IL 68456A IL 68456 A IL68456 A IL 68456A IL 6845683 A IL6845683 A IL 6845683A IL 68456 A IL68456 A IL 68456A
Authority
IL
Israel
Prior art keywords
vehicles
perfluoro
pharmaceutical compositions
substituted compounds
substituted
Prior art date
Application number
IL68456A
Other languages
English (en)
Other versions
IL68456A0 (en
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of IL68456A0 publication Critical patent/IL68456A0/xx
Publication of IL68456A publication Critical patent/IL68456A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL68456A 1982-04-05 1983-04-21 Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles IL68456A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36553982A 1982-04-05 1982-04-05

Publications (2)

Publication Number Publication Date
IL68456A0 IL68456A0 (en) 1983-07-31
IL68456A true IL68456A (en) 1989-09-28

Family

ID=23439275

Family Applications (1)

Application Number Title Priority Date Filing Date
IL68456A IL68456A (en) 1982-04-05 1983-04-21 Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles

Country Status (12)

Country Link
EP (1) EP0091313B1 (en, 2012)
KR (1) KR880002038B1 (en, 2012)
AT (1) ATE56138T1 (en, 2012)
AU (1) AU557980B2 (en, 2012)
CA (1) CA1295948C (en, 2012)
DE (1) DE3381854D1 (en, 2012)
GR (1) GR78151B (en, 2012)
IE (1) IE56412B1 (en, 2012)
IL (1) IL68456A (en, 2012)
NZ (1) NZ203802A (en, 2012)
PT (1) PT76504B (en, 2012)
WO (1) WO1983003544A1 (en, 2012)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8320264A (nl) * 1982-08-17 1984-07-02 Sun Tech Inc Perfluorkoolstof-emulsies, hun bereiding en hun toepassing in de therapie.
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
WO1993009833A1 (en) * 1991-11-14 1993-05-27 Alliance Pharmaceutical Corp. Method and apparatus for partial liquid ventilation using fluorocarbons
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
EP0664705B1 (en) * 1993-08-18 2000-10-04 Alcon Laboratories, Inc. Compositions of ergoline derivatives for the treatment of glaucoma
ATE206441T1 (de) 1994-03-04 2001-10-15 Univ Washington Block- und pfropfcopolymere und dazu gehöriges verfahren
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
DK1452171T3 (da) * 2000-10-13 2010-04-06 Nova Bio Pharma Technologies Ltd Farmaceutiske væskesuspensioner
CN100339066C (zh) * 2000-10-13 2007-09-26 剑桥生物稳定性有限公司 稳定的注射液组合物和方法
DE102006040450B3 (de) * 2006-08-24 2008-04-24 Coty Prestige Lancaster Group Gmbh Verwendung einer Zusammensetzung für die Hautbehandlung nach Röntgenbestrahlung
WO2014041071A1 (en) * 2012-09-12 2014-03-20 Novaliq Gmbh Semifluorinated alkane compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
BE629985A (en, 2012) * 1962-11-29
US3490923A (en) * 1966-07-28 1970-01-20 Du Pont Aerosol propellant composition used in dispensing foods
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US3929662A (en) * 1973-12-18 1975-12-30 Wave Energy Systems Liquid or gas phase sterilizing and cleaning composition containing an aldehyde and a fluoro or perfluoro compound
US4187252A (en) * 1977-08-26 1980-02-05 Suntech, Inc. Tetramethylpentane blood substitutes
US4110474A (en) * 1977-08-26 1978-08-29 Suntech, Inc. Tetramethylpentane blood substitutes
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
JPH08221312A (ja) * 1995-02-14 1996-08-30 Hitachi Ltd メモリカード装置

Also Published As

Publication number Publication date
GR78151B (en, 2012) 1984-09-26
EP0091313A3 (en) 1985-05-22
IE830776L (en) 1983-10-05
NZ203802A (en) 1985-07-31
WO1983003544A1 (en) 1983-10-27
AU557980B2 (en) 1987-01-15
EP0091313A2 (en) 1983-10-12
PT76504A (en) 1983-05-01
IL68456A0 (en) 1983-07-31
IE56412B1 (en) 1991-07-31
CA1295948C (en) 1992-02-18
KR880002038B1 (ko) 1988-10-13
AU1313883A (en) 1983-10-13
PT76504B (en) 1986-02-27
EP0091313B1 (en) 1990-09-05
ATE56138T1 (de) 1990-09-15
KR840004366A (ko) 1984-10-15
DE3381854D1 (de) 1990-10-11

Similar Documents

Publication Publication Date Title
IL68456A (en) Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles
GB2129691B (en) Devices for administering medicaments to patients
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
GB2100605B (en) Bandage for administering drugs.
GB2142237B (en) Pharmaceutical compositions for percutaneous administration
NL930112I1 (nl) Benzazepine-2-onen werkwijzen ter bereiding daarvan farmaceutische preparaten die deze verbindingen bevatten alsmede verbindingen voor de therapeutische toepassing
GB8602264D0 (en) Administering medicaments to patients
ES8304147A1 (es) Procedimiento para la preparacion de mono-esteres amonio-al-cohilicos de acidos alcanol-fosforicos
DE3779053D1 (en, 2012)
DE3378523D1 (en) Pharmaceutical formulations
FI822683A7 (fi) Inertti täyteaine lääkeaineseosta varten.
GB2085729B (en) Pharmaceutical composition for oral administration containing coagulation factor viii
AU7080587A (en) Therapeutic compositions for veterinary use
HUT62471A (en) Process for producing pharmaceutical compositions comprising ipriflavone
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
ZA81927B (en) Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds
GB2052980B (en) Pharmaceutical composition for oral administration comprising methoxsalen
ZA814430B (en) Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator
PT76999A (en) Process for preparing pharmaceutical compositions having analgesic activity
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
ZA837318B (en) Device for administering medicaments to patients
IT8349055A0 (it) B-osso-l-carbammoil-pirrolpropionitrile, procedimento per la loro produzione, preparati farmaceutici con tenenti questi composti, nonche' il loro impiego terapeutico
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
GB2142238B (en) Pharmaceutical compositions for percutaneous administration
ZA832489B (en) Perfluorohydrocarbons as vehicles for administering drugs

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees